Champions Oncology, Inc. (CSBR)
4.97
+0.01
(+0.20%)
USD |
NASDAQ |
Aug 24, 16:00
4.99
+0.02
(+0.40%)
After-Hours: 20:00
Champions Oncology Gross Profit Margin (Quarterly) : 48.77% for April 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 48.77% |
| January 31, 2026 | 44.59% |
| October 31, 2025 | 49.32% |
| July 31, 2025 | 40.31% |
| April 30, 2025 | 37.96% |
| January 31, 2025 | 58.83% |
| October 31, 2024 | 41.97% |
| July 31, 2024 | 49.70% |
| April 30, 2024 | 48.22% |
| January 31, 2024 | 34.70% |
| October 31, 2023 | 42.82% |
| July 31, 2023 | 38.83% |
| April 30, 2023 | 43.86% |
| January 31, 2023 | 39.72% |
| October 31, 2022 | 47.88% |
| July 31, 2022 | 48.69% |
| April 30, 2022 | 51.69% |
| January 31, 2022 | 51.44% |
| October 31, 2021 | 52.41% |
| July 31, 2021 | 52.05% |
| April 30, 2021 | 46.49% |
| January 31, 2021 | 57.24% |
| October 31, 2020 | 44.21% |
| July 31, 2020 | 44.11% |
| April 30, 2020 | 42.96% |
| Date | Value |
|---|---|
| January 31, 2020 | 52.01% |
| October 31, 2019 | 49.10% |
| July 31, 2019 | 44.31% |
| April 30, 2019 | 44.26% |
| January 31, 2019 | 46.67% |
| October 31, 2018 | 48.44% |
| July 31, 2018 | 50.47% |
| April 30, 2018 | 42.73% |
| January 31, 2018 | 51.34% |
| October 31, 2017 | 49.01% |
| July 31, 2017 | 47.51% |
| April 30, 2017 | 30.89% |
| January 31, 2017 | 32.51% |
| October 31, 2016 | 50.57% |
| July 31, 2016 | 31.25% |
| April 30, 2016 | 17.45% |
| January 31, 2016 | 17.48% |
| October 31, 2015 | 32.31% |
| July 31, 2015 | 19.45% |
| April 30, 2015 | 31.56% |
| January 31, 2015 | -7.98% |
| October 31, 2014 | 8.66% |
| July 31, 2014 | 9.94% |
| April 30, 2014 | 37.39% |
| January 31, 2014 | 56.04% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Medpace Holdings, Inc. | 27.56% |
| Avantor, Inc. | 31.73% |
| Personalis, Inc. | 21.21% |
| Adaptive Biotechnologies Corp. | 70.15% |
| 10X Genomics, Inc. | 74.36% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -29.39% |
| Return on Assets | -3.96% |
| Return on Invested Capital | -12.43% |
| Profit Margin (Quarterly) | -4.82% |
| Operating Margin (Quarterly) | -3.77% |
| Return on Net Operating Assets | -5.54% |